Chemopreventive Potential of Artemisinin and Rubus occidentalis in the Progression of Oral Leukoplakia to Oral Cancer: A Preclinical Murine Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178120 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Maria Leticia de Almeida Lança und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience and Oral Diagnosis, Institute of Science and Technology, University of São Paulo State, Avenue Engenheiro Francisco José Lon…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Artemisinins, Leukoplakia, Oral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, São Paulo Research Foundation, Coordination for the Improvement of Higher Education Personnel.
Abstract (Originalsprache)
Oral leukoplakia (OL) is the most common potentially malignant oral disorder, with variable risk of progression to oral squamous cell carcinoma (OSCC). This study evaluated the chemopreventive and immunomodulatory potential of Artemisinin (ART) and Rubus occidentalis (RO), alone or combined (ARO), in a 4NQO-induced murine model. Mice received 4NQO (100 µg/mL) in drinking water, and treatments began at week 8. Animals were euthanized at weeks 12 and 16 for histological, apoptotic (caspases-3, -8, -9; calreticulin), inflammatory (IL-1β, IL-10, HMGB1), and immune (CD8, CD68, CD56, IFN-γ, GM-CSF) marker analyses. RO-treated animals showed delayed malignant transformation, with no carcinomas at week 16 and increased expression of caspase-9, calreticulin, HMGB1, IFN-γ, and GM-CSF, indicating transient activation of antitumor immune responses. ART-treated mice showed increased CD68 and reduced CD56 expression, suggesting an immunosuppressive profile and higher carcinoma incidence. The ARO combination did not improve outcomes beyond ART alone. These findings support the immunomodulatory and pro-apoptotic effects of RO in delaying OL progression, highlighting its chemopreventive potential. ART showed limited benefit under current conditions, warranting further investigation into dose optimization and synergistic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioscience and Oral Diagnosis, Institute of Science and Technology, University of São Paulo State, Avenue Engenheiro Francisco José Longo, 777, São José dos Campos, São Paulo 12245-000, Brazil.
ORCID-Profile: Maria Leticia de Almeida Lança, Isabella Souza Malta, Daniela Oliveira Meneses, Luciana Yamamoto Almeida, Estela Kaminagakura
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- São Paulo Research Foundation
- Coordination for the Improvement of Higher Education Personnel
- PIBIC
Zitieren
APA
Lança, M. L. A., Conceição, N. S. C. D., Malta, I. S., Meneses, D. O., Almeida, L. Y., & Kaminagakura, E. (2025). Chemopreventive Potential of Artemisinin and Rubus occidentalis in the Progression of Oral Leukoplakia to Oral Cancer: A Preclinical Murine Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178120
Vancouver
Lança MLA, Conceição NSCD, Malta IS, Meneses DO, Almeida LY, Kaminagakura E. Chemopreventive Potential of Artemisinin and Rubus occidentalis in the Progression of Oral Leukoplakia to Oral Cancer: A Preclinical Murine Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178120
BibTeX
@article{Lana2025,
author = {Lança, Maria Leticia de Almeida and Conceição, Nathan Steven Cezar da and Malta, Isabella Souza and Meneses, Daniela Oliveira and Almeida, Luciana Yamamoto and Kaminagakura, Estela},
title = {Chemopreventive Potential of Artemisinin and Rubus occidentalis in the Progression of Oral Leukoplakia to Oral Cancer: A Preclinical Murine Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178120}
}
EUVIMED